PRTN3 and rheumatoid arthritis: Our study demonstrates the use of a panel of ACPA specific for the citrullinated epitopes present on our arrays as well as cytokines, in a multiplex fashion, to improve preclinical diagnostic accuracy and to narrow the temporal period during which an at-risk individual will develop RA.